Sökning: id:"swepub:oai:DiVA.org:hh-48893" >
Animal Models of Rh...
-
Tuncel, J.Harvard Medical School, Boston, Massachusetts, United States of America; Karolinska Institutet, Stockholm, Sweden
(författare)
Animal Models of Rheumatoid Arthritis (I) : Pristane-Induced Arthritis in the Rat
- Artikel/kapitelEngelska2016
Förlag, utgivningsår, omfång ...
-
2016-05-26
-
Public Library of Science (PLoS),2016
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:hh-48893
-
https://urn.kb.se/resolve?urn=urn:nbn:se:hh:diva-48893URI
-
https://doi.org/10.1371/journal.pone.0155936DOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:133685384URI
-
https://urn.kb.se/resolve?urn=urn:nbn:se:hh:diva-48402URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
BACKGROUND: To facilitate the development of therapies for rheumatoid arthritis (RA), the Innovative Medicines Initiative BTCure has combined the experience from several laboratories worldwide to establish a series of protocols for different animal models of arthritis that reflect the pathogenesis of RA. Here, we describe chronic pristane-induced arthritis (PIA) model in DA rats, and provide detailed instructions to set up and evaluate the model and for reporting data. METHODS: We optimized dose of pristane and immunization procedures and determined the effect of age, gender, and housing conditions. We further assessed cage-effects, reproducibility, and frequency of chronic arthritis, disease markers, and efficacy of standard and novel therapies. RESULTS: Out of 271 rats, 99.6% developed arthritis after pristane-administration. Mean values for day of onset, day of maximum arthritis severity and maximum clinical scores were 11.8+/-2.0 days, 20.3+/-5.1 days and 34.2+/-11 points on a 60-point scale, respectively. The mean frequency of chronic arthritis was 86% but approached 100% in long-term experiments over 110 days. Pristane was arthritogenic even at 5 microliters dose but needed to be administrated intradermally to induce robust disease with minimal variation. The development of arthritis was age-dependent but independent of gender and whether the rats were housed in conventional or barrier facilities. PIA correlated well with weight loss and acute phase reactants, and was ameliorated by etanercept, dexamethasone, cyclosporine A and fingolimod treatment. CONCLUSIONS: PIA has high incidence and excellent reproducibility. The chronic relapsing-remitting disease and limited systemic manifestations make it more suitable than adjuvant arthritis for long-term studies of joint-inflammation and screening and validation of new therapeutics.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Haag, S.Karolinska Institutet, Stockholm, Sweden
(författare)
-
Hoffmann, M. H.University of Erlangen-Nuremberg, Erlangen, Germany; Medical University of Vienna, Vienna, Austria,Redoxis AB, Medicon Village, Lund, Sweden
(författare)
-
Yau, A. C.Karolinska Institutet,Karolinska Institutet, Stockholm, Sweden
(författare)
-
Hultqvist, M.Redoxis AB, Medicon Village, Lund, Sweden
(författare)
-
Olofsson, P.Redoxis AB, Medicon Village, Lund, Sweden
(författare)
-
Bäcklund, J.Karolinska Institutet,Karolinska Institutet, Stockholm, Sweden
(författare)
-
Nandakumar, Kutty Selva,1965-Karolinska Institutet,Karolinska Institutet, Stockholm, Sweden(Swepub:hh)kutnam
(författare)
-
Weidner, D.University of Erlangen-Nuremberg, Erlangen, Germany
(författare)
-
Fischer, A.Medical University of Vienna, Vienna, Austria
(författare)
-
Leichsenring, A.Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany
(författare)
-
Lange, F.Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany
(författare)
-
Haase, C.Novo Nordisk A/S, Malov, Denmark
(författare)
-
Lu, S.Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, PR China
(författare)
-
Gulko, P. S.Icahn School of Medicine at Mount Sinai, New York, New York, United States of America,Medical University of Vienna, Vienna, Austria
(författare)
-
Steiner, G.Medical University of Vienna, Vienna, Austria
(författare)
-
Holmdahl, R.Karolinska Institutet,Karolinska Institutet, Stockholm, Sweden
(författare)
-
Harvard Medical School, Boston, Massachusetts, United States of America; Karolinska Institutet, Stockholm, SwedenKarolinska Institutet, Stockholm, Sweden
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:PLOS ONE: Public Library of Science (PLoS)11:51932-6203
Internetlänk
Hitta via bibliotek
-
PLOS ONE
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas
- Av författaren/redakt...
-
Tuncel, J.
-
Haag, S.
-
Hoffmann, M. H.
-
Yau, A. C.
-
Hultqvist, M.
-
Olofsson, P.
-
visa fler...
-
Bäcklund, J.
-
Nandakumar, Kutt ...
-
Weidner, D.
-
Fischer, A.
-
Leichsenring, A.
-
Lange, F.
-
Haase, C.
-
Lu, S.
-
Gulko, P. S.
-
Steiner, G.
-
Holmdahl, R.
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Reumatologi och ...
- Artiklar i publikationen
-
PLOS ONE
- Av lärosätet
-
Högskolan i Halmstad
-
Karolinska Institutet